Exelixis



Ebit Cambio Fecha
Acadia Pharmaceuticals USD 6.99M 24.66M 2024-12
Agios Pharmaceuticals USD -106629000 18.41M 2025-03
Amgen USD 3.6B 434M 2025-03
AstraZeneca USD 4.8B 604M 2025-03
Bayer EUR 855M 588M 2024-12
BioMarin Pharmaceutical USD 223.89M 62.49M 2025-03
Bristol-Myers Squibb USD 4.18B 30M 2025-03
Cytokinetics USD -139040000 1.76M 2024-12
Eisai JPY 18.98B 12.87B 2024-03
Eli Lilly USD 3.7B 1.93B 2025-03
Exelixis USD 163.46M 27.38M 2024-12
Genmab DKK 2.16B 58M 2024-12
Glaxosmithkline GBP 1.83B 1.76B 2024-12
Incyte USD 283.64M 92.62M 2025-03
Ionis Pharmaceuticals USD -146000000 36M 2025-03
MacroGenics USD -52837000 107.35M 2024-12
Merck USD 5.22B 339M 2024-12
Moderna USD -963000000 283M 2025-03
Neurocrine Biosciences USD 142M 41.8M 2024-12
Novartis USD 4.86B 286M 2024-12
Pfizer USD 5.93B 1.31B 2025-03
Sanofi EUR 2.22B 2.84B 2024-12
Takeda JPY 58B 129.82B 2024-12
Ultragenyx Pharmaceutical USD -122278000 9.71M 2024-12
Xencor USD -13178000 47.7M 2024-12



Exelixis - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.